236 related articles for article (PubMed ID: 24297510)
1. Distinct roles of Akt1 in regulating proliferation, migration and invasion in HepG2 and HCT 116 cells.
Chen L; Kang QH; Chen Y; Zhang YH; Li Q; Xie SQ; Wang CJ
Oncol Rep; 2014 Feb; 31(2):737-44. PubMed ID: 24297510
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
5. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
6. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
Wu L; Zheng J; Chen P; Liu Q; Yuan Y
Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
[TBL] [Abstract][Full Text] [Related]
7. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinoma.
Chen X; Bo L; Zhao X; Chen Q
Mol Med Rep; 2015 May; 11(5):3900-7. PubMed ID: 25607810
[TBL] [Abstract][Full Text] [Related]
9. RUNX2 promotes hepatocellular carcinoma cell migration and invasion by upregulating MMP9 expression.
Wang Q; Yu W; Huang T; Zhu Y; Huang C
Oncol Rep; 2016 Nov; 36(5):2777-2784. PubMed ID: 27666365
[TBL] [Abstract][Full Text] [Related]
10. Extracellular polyamines-induced proliferation and migration of cancer cells by ODC, SSAT, and Akt1-mediated pathway.
Dai F; Yu W; Song J; Li Q; Wang C; Xie S
Anticancer Drugs; 2017 Apr; 28(4):457-464. PubMed ID: 28157137
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion.
Li Q; Wang G; Shan JL; Yang ZX; Wang HZ; Feng J; Zhen JJ; Chen C; Zhang ZM; Xu W; Luo XZ; Wang D
J Gastroenterol Hepatol; 2010 Jan; 25(1):164-71. PubMed ID: 19793168
[TBL] [Abstract][Full Text] [Related]
12. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
13. Dioscorea nipponica Attenuates Migration and Invasion by Inhibition of Urokinase-Type Plasminogen Activator through Involving PI3K/Akt and Transcriptional Inhibition of NF-[Formula: see text]B and SP-1 in Hepatocellular Carcinoma.
Hsieh MJ; Yeh CB; Chiou HL; Hsieh MC; Yang SF
Am J Chin Med; 2016; 44(1):177-95. PubMed ID: 26916922
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
15. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
16. miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma.
Li Q; Ding C; Chen C; Zhang Z; Xiao H; Xie F; Lei L; Chen Y; Mao B; Jiang M; Li J; Wang D; Wang G
J Gastroenterol Hepatol; 2014 Apr; 29(4):835-42. PubMed ID: 24219032
[TBL] [Abstract][Full Text] [Related]
17. Chloride intracellular channel 1 participates in migration and invasion of hepatocellular carcinoma by targeting maspin.
Wei X; Li J; Xie H; Wang H; Wang J; Zhang X; Zhuang R; Lu D; Ling Q; Zhou L; Xu X; Zheng S
J Gastroenterol Hepatol; 2015 Jan; 30(1):208-16. PubMed ID: 24989236
[TBL] [Abstract][Full Text] [Related]
18. EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activity.
Dou CY; Cao CJ; Wang Z; Zhang RH; Huang LL; Lian JY; Xie WL; Wang LT
Oncol Rep; 2016 Jun; 35(6):3489-95. PubMed ID: 27108677
[TBL] [Abstract][Full Text] [Related]
19. Slit2 and Robo1 induce opposing effects on metastasis of hepatocellular carcinoma Sk-hep-1 cells.
Yuan M; Guo H; Li J; Sui C; Qin Y; Wang J; Khan YH; Ye L; Xie F; Wang H; Yuan L; Ye J
Int J Oncol; 2016 Jul; 49(1):305-15. PubMed ID: 27176045
[TBL] [Abstract][Full Text] [Related]
20. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
Liu S; Zhang W; Liu K; Ji B; Wang G
Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
